Contribution of postprandial and fasting plasma glucose to each of 3 identical meals during the day and also to diurnal hyperglycaemia in persons with type 2 diabetes

被引：0

作者：

Dunseath, Gareth

Peter, Rajesh

Chudleigh, Richard

Luzio, Stephen D.

Owens, David R.

机构：

来源：

DIABETES | 2007年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A681 / A682

页数：2

共 44 条

[31] Relative contributions of fasting vs postprandial hyperglycaemia to overall glycaemic control in newly-diagnosed type 2 diabetes before and following 3 months' treatment
Sun, Y.
Luo, Y.
Xie, C.
Ma, J.
Jones, K.
Horowitz, M.
Rayner, C.
Wu, T.
DIABETOLOGIA, 2024, 67 : S270 - S270
[32] Contribution of fasting and postprandial plasma glucose to HbA1c in people with type 2 diabetes on basal-bolus insulin: a meta-analysis of insulin lispro clinical trials
Liao, B.
Chen, Y.
Chigutsa, F.
de Oliveira, C. Piras
DIABETOLOGIA, 2020, 63 (SUPPL 1) : S332 - S332
[33] Factors Associated with the Effects of Ipragliflozin on the Diurnal Profiles of Plasma Glucose and 3-hydroxybutyrate in Patients with Type 2 Diabetes
Nakayama, Hitomi
Yoshinobu, Satoko
Kawano, Seiko
Tsuruta, Munehisa
Nohara, Masayuki
Hasuo, Rika
Akasu, Shoko
Tokubuchi, Ichiro
Wada, Nobuhiko
Hirao, Saori
Iwata, Shinpei
Kaku, Hiroo
Otabe, Shuichi
Tajiri, Yuji
Yamada, Kentaro
DIABETES, 2015, 64 : A320 - A320
[34] Fasting and postprandial plasma glucose contribution to glycated haemoglobin and time in range in people with type 2 diabetes on basal and bolus insulin therapy: Results from a pooled analysis of insulin lispro clinical trials
Liao, Birong
Chen, Yun
Chigutsa, Farai
Piras de Oliveira, Carolina
DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1571 - 1579
[35] Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China
Zhang, Fang
Wan, Qin
Cao, Hongyi
Tang, Lizhi
Li, Daigang
Lu, Qingguo
Yan, Zhe
Li, Jing
Yang, Qiu
Zhang, Yuwei
Tong, Nanwei
BMJ OPEN, 2018, 8 (05):
[36] HbA1c target attainment in patients with type 2 diabetes receiving iGlarLixi who reach postprandial glucose and fasting plasma glucose targets in the LixiLan-L trial
Davidson, J.
Chao, J.
Saremi, A.
Dex, T.
Leiter, L.
DIABETOLOGIA, 2018, 61 : S385 - S385
[37] Day-to-Day Variability of Fasting Self-Measured Plasma Glucose (SMPG) Correlates with Risk of Hypoglycemia in Adults with Type 1 (T1D) or Type 2 Diabetes (T2D)
Bailey, Timothy S.
Bhargava, Anuj
De Vries, J. Hans
Gerety, Gregg
Gumprecht, Janusz
Lane, Wendy S.
Wysham, Carol H.
Bak, Britta Anker
Hachmann-Nielsen, Elise
Philis-Tsimikas, Athena
DIABETES, 2017, 66 : A104 - A105
[38] Differences in cardiac organ damage in individuals with hyperglycaemia and type 2 diabetes identified by 1-hour plasma glucose during an OGTT according to the IDF criteria
Riccio, A.
Cefalo, C. M. A.
Fiorentino, T.
Succurro, E.
Andreozzi, F.
Sciacqua, A.
Sesti, G.
DIABETOLOGIA, 2024, 67 : S461 - S461
[39] Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose
Clemmons, DR
Moses, AC
Sommer, A
Jacobson, W
Rogol, AD
Sleevi, MR
Allan, G
GROWTH HORMONE & IGF RESEARCH, 2005, 15 (04) : 265 - 274
[40] Effects of Insulin Degludec and Insulin Glargine U300 on Day-to-Day Fasting Plasma Glucose Variability in Individuals with Type 1 Diabetes: A Multicenter, Randomized, Crossover Study (Kobe Best Basal Insulin Study 2)
Miura, Hiroshi
Sakaguchi, Kazuhiko
Okada, Yuko
Otowa-Suematsu, Natsu
Yamada, Tomoko
So, Anna
Komada, Hisako
Hirota, Yushi
Kishi, Minoru
Takeda, Akihiko
Tominaga, Yoichi
Nakamura, Tomoaki
Kuroki, Yasuo
Matsuda, Tomokazu
Iida, Keiji
Kajikawa, Michiko
Ohara, Takeshi
Yokota, Kazuki
Hara, Kenta
Tateya, Sanshiro
Tamori, Yoshikazu
Ogawa, Wataru
DIABETES THERAPY, 2018, 9 (06) : 2399 - 2406

← 1 2 3 4 5 →